4
Changes in Ownership
HCW Biologics Inc. Filed Acc 0001209191-22-047721
Chief Financial Officer bought 90,300 shares at an average $2.54 ($229,747)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Byam Rebecca Chief Financial Officer | 2022-08-24 | Purchase | +50,000 | $2.50 | $125,225 | 205,452 | D: show line 1 in the form |
| Byam Rebecca Chief Financial Officer | 2022-08-25 | Purchase | +40,300 | $2.59 | $104,522 | 245,752 | D: show line 2 in the form |
| Open-market purchases · 90,300 sh · avg $2.54 · $229,747 | |||||||
Loading xslF345X03/doc4.xml…